PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 36565362

  • 1. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
    Vural F, Vural B, Kardaş E, Ertürk Coşkun AD, Yildirim İ.
    Arch Gynecol Obstet; 2023 Apr; 307(4):1083-1090. PubMed ID: 36565362
    [Abstract] [Full Text] [Related]

  • 2. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 3. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 4. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR.
    Hum Reprod; 2021 Dec 27; 37(1):109-118. PubMed ID: 34741176
    [Abstract] [Full Text] [Related]

  • 5. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 27; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 6. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G, Mumusoglu S, Coskun ZY, Yarali H, Yildiz BO.
    Reprod Biomed Online; 2019 Sep 27; 39(3):522-529. PubMed ID: 31182353
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P, Kulkarni A, Dilgil M, Dhir P, Shah A, Gudi A, Homburg R.
    Gynecol Endocrinol; 2017 Oct 27; 33(10):801-806. PubMed ID: 28454499
    [Abstract] [Full Text] [Related]

  • 8. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A, Hund M, Buck K, Meun C, Sillman J, Laven JSE.
    Fertil Steril; 2021 Oct 27; 116(4):1149-1157. PubMed ID: 34579824
    [Abstract] [Full Text] [Related]

  • 9. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug 27; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 10. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB, Vanky E, Carlsen SM.
    Hum Reprod; 2012 Aug 27; 27(8):2494-502. PubMed ID: 22693172
    [Abstract] [Full Text] [Related]

  • 11. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R.
    Fertil Steril; 2015 Feb 27; 103(2):537-41. PubMed ID: 25467043
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr 27; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 13. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
    Zhao Y, Zhao Y, Wang C, Liang Z, Liu X.
    Endocr Pract; 2019 Oct 27; 25(10):1056-1066. PubMed ID: 31414908
    [Abstract] [Full Text] [Related]

  • 14. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF.
    Hum Reprod Update; 2014 Oct 27; 20(3):334-52. PubMed ID: 24345633
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Anti-müllerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome.
    Ozay AC, Emekcı Ozay O, Gulekli B.
    Ginekol Pol; 2020 Oct 27; 91(11):661-667. PubMed ID: 33301159
    [Abstract] [Full Text] [Related]

  • 16. AMH as part of the diagnostic PCOS workup in large epidemiological studies.
    Piltonen TT, Komsi E, Morin-Papunen LC, Korhonen E, Franks S, Järvelin MR, Arffman RK, Ollila MM.
    Eur J Endocrinol; 2023 Jun 07; 188(6):547-554. PubMed ID: 37294941
    [Abstract] [Full Text] [Related]

  • 17. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T, Doherty DA, Dickinson JE, Juul A, Hart R, Bräuner EV, Hickey M.
    Psychoneuroendocrinology; 2021 Mar 07; 125():105104. PubMed ID: 33352473
    [Abstract] [Full Text] [Related]

  • 18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES).
    Endocr Pract; 2015 Nov 07; 21(11):1291-300. PubMed ID: 26509855
    [Abstract] [Full Text] [Related]

  • 19. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, Grayson K.
    Hum Reprod; 2013 Apr 07; 28(4):1077-83. PubMed ID: 23377771
    [Abstract] [Full Text] [Related]

  • 20. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
    Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA.
    Hum Reprod; 2020 Oct 01; 35(10):2294-2302. PubMed ID: 32918081
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.